# Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

> **NCT00868569** · PHASE4 · UNKNOWN · sponsor: **Fudan University** · enrollment: 200 (estimated)

## Conditions studied

- Liver Metastasis
- Colorectal Cancer

## Interventions

- **PROCEDURE:** TACE + folfox 4
- **PROCEDURE:** TAC + folfox4

## Key facts

- **NCT ID:** NCT00868569
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868569, "Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00868569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*